Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1212J

PerCP/Cyanine5.5 Anti-Human CD20 Antibody[2H7]

PerCP/Cyanine5.5 Anti-Human CD20 Antibody[2H7]

Regular price $275.00 USD
Regular price Sale price $275.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Concentration
Host

PerCP/Cyanine5.5 Anti-Human CD20 Antibody[2H7Introducing the PERCP/Cyanine5.5 Anti-Human CD20 Antibody [2H7], a cutting-edge product designed to revolutionize the field of immunology. This antibody, meticulously developed by our team of experts, offers unparalleled specificity and sensitivity in detecting and targeting the CD20 antigen on human cells.

The PERCP/Cyanine5.5 Anti-Human CD20 Antibody [2H7] is a highly reliable tool for researchers and clinicians alike, enabling precise identification and characterization of CD20-expressing cells. Its exceptional performance is attributed to the advanced PERCP/Cyanine5.5 conjugation, which ensures optimal signal intensity and minimal background noise.

This antibody's exceptional binding affinity and selectivity make it an invaluable asset in various applications, including flow cytometry, immunohistochemistry, and immunofluorescence. Its versatility allows for comprehensive analysis of CD20 expression patterns in diverse biological samples, facilitating a deeper understanding of disease mechanisms and therapeutic interventions.

Furthermore, the PERCP/Cyanine5.5 Anti-Human CD20 Antibody [2H7] exhibits exceptional stability and consistency, ensuring reproducible results across experiments and minimizing experimental variability. Its long shelf life and robust performance make it an ideal choice for laboratories and research institutions seeking reliable and high-quality reagents.

In summary, the PERCP/Cyanine5.5 Anti-Human CD20 Antibody [2H7] represents a breakthrough in immunological research, offering unmatched precision, sensitivity, and reliability. With its exceptional performance and broad range of applications, this antibody is poised to drive advancements in the understanding and treatment of CD20-associated diseases.

View full details